CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 124 filers reported holding CARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | -75.0% | 10,100 | -33.6% | 0.00% | -100.0% |
| Q4 2021 | $24,000 | -29.4% | 15,200 | -49.7% | 0.00% | 0.0% |
| Q3 2021 | $34,000 | -70.9% | 30,200 | -35.1% | 0.00% | -66.7% |
| Q2 2021 | $117,000 | -64.8% | 46,500 | +204.3% | 0.00% | -83.3% |
| Q1 2021 | $332,000 | +3588.9% | 15,282 | +27.4% | 0.02% | – |
| Q4 2020 | $9,000 | +125.0% | 12,000 | -10.4% | 0.00% | – |
| Q3 2020 | $4,000 | -75.0% | 13,400 | -35.0% | 0.00% | -100.0% |
| Q1 2020 | $16,000 | -11.1% | 20,600 | +73.1% | 0.00% | 0.0% |
| Q4 2019 | $18,000 | -93.0% | 11,900 | +10.7% | 0.00% | -93.8% |
| Q3 2018 | $258,000 | +8500.0% | 10,753 | +7.5% | 0.02% | – |
| Q2 2018 | $3,000 | -72.7% | 10,000 | -14.5% | 0.00% | -100.0% |
| Q2 2017 | $11,000 | -70.3% | 11,700 | -20.9% | 0.00% | -50.0% |
| Q1 2017 | $37,000 | – | 14,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |